Area Prescribing Committee

The Barnsley Area Prescribing Committee (APC) meets on a monthly basis. See below for the latest ratified minutes and APC Memo.

Latest APC Memo

January 2025   

Latest APC Ratified Minutes

December 2024

 

APC Forms

APC New Drug Application and Assessment Procedure

APC Interface Issues Reporting Form

 

APC Memos 2025

January 2025

 

APC Memos 2024

December 2024

October & November 2024

September 2024      ADHD Medication Shortage FAQs

July & August 2024

June 2024

May 2024

April 2024 - Using Glycopyrronium as an alternative antimuscarinic when unable to source Hyoscine Butylbromide (Buscopan®) 

February 2024

January 2024

APC Minutes 2024

December 2024

November 2024

October 2024

September 2024

August 2024

July 2024

June 2024

May 2024

April 2024

March 2024 - meeting cancelled

February 2024

January 2024

APC Memos 2023

December 2023

November 2023 - Greenlight Alert - Liquid Medicines & Greenlight Alert - Medicines and Suicide Ideation

October 2023 - ADHD Medication Shortage FAQs & ADHD Medication Shortage Patient Carer Information

September 2023

August 2023 - Greenlight Alert - CBD containing products & Greenlight Alert - Propranolol

June-July 2023 - GLP-1 receptor agonist shortage and summary of associated key points from Barnsley APC meeting 12th July 2023

May 2023

April 2023

March 2023

February 2023

January 2023 

APC Minutes 2023

December 2023

November 2023

October 2023

September 2023

August 2023

July 2023

June 2023

May 2023

April 2023

March 2023

February 2023

January 2023

APC Memos 2022

December 2022

November 2022

October 2022

August/September 2022

August/September 2022 -  ENC - Cenobamate (Ontozry®) information for Community Pharmacies

July 2022

July 2022 ENC A - Barnsley Lipid Management for Primary Prevention of Cardiovascular Disease in Adults

July 2022 ENC B - Barnsley Severe Hyperlipidaemia Pathway

July 2022 ENC C - Aripiprazole Shortage Memo

June 2022

May 2022

  • MHRA Drug Safety Update
  • Guidelines for approved choice of blood glucose testing strips, meters and lancets
  • SYB Shared Care Protocol for Epilepsy in Adults [UPDATED]
  • SYB Shared Care Protocol for the treatment of Parkinson’s disease [UPDATED]

April 2022

  • Patient Information Leaflet: Unlicensed and ‘Off-label’ medicines [UPDATED] 
  • Patient Information Leaflet: Trial of stopping your overactive bladder drug [UPDATED]
  • Wound Care
  • Ganciclovir 0.15% Eye Gel Amber-G guideline [UPDATED] 
  • Shared Care Guideline for Lithium Therapy [UPDATED]
  • Morphine Injection
  • Primary Care Medicines Optimisation Scheme QIPP areas involving specific brands or preparations 22/23

March 2022

  • Calcium and Vitamin D, and Vitamin D Summary of formulary choices in adults over 18 years [UPDATED]
  • Sheffield Area Prescribing Group (APG) shared care protocol for topical testosterone replacement therapy in post-menopausal women
  • Guidelines with extended review dates
  • COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry

March 2022 Enc - Guidelines with extended review dates

February 2022

  • Possible Alternatives to Unlicensed Specials [UPDATED]
  • Calcium and Vitamin D (combination) and Vitamin D Summary of Formulary Choices in Adults over 18 years [UPDATED]
  • Osteoporosis Drug Holiday Guidelines for GPs [UPDATED]

January 2022

  • Liothyronine (including Armour® Thyroid and liothyronine combination products) Area Prescribing Committee Position Statement [NEW]
  • Guidance for Oral Paracetamol dosing [UPDATED] 
  • Management of Osteoporosis and Fragility Fracture Risk Barnsley Guideline [UPDATED]
  • SYB Trans man and Trans woman  prescribing guidelines [UPDATED]
  • Haloperidol (Haldol®): reminder of risks when used in elderly patients for the acute treatment of delirium

APC Minutes 2022

December 2022

November 2022

October 2022

September 2022

August 2022

July 2022

June 2022

May 2022

April 2022

March 2022

February 2022

January 2022